EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Systemic Azithromycin as an Adjunct to Non‐Surgical Subgingival Instrumentation in the Treatment of Stage III / IV , Grade C Periodontitis: 12‐Month Clinical, Microbiological and Cytokine Results of a Randomised Controlled Trial

Srinivas Sulugodu Ramachandra iD, Valerie Woodford iD, Pingping Han iD, Ryan S B Lee iD, Sašo Ivanovski iD

Journal of Clinical Periodontology · 2025-05 · 52 (5) · 666-680

DOI: 10.1111/jcpe.14150 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 24.03.2025. Verfasst von Srinivas Sulugodu Ramachandra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), School of Dentistry, The University of Queensland, Brisbane, Queensland,…. Hauptthemen laut MEDLINE: Azithromycin, Anti-Bacterial Agents, Cytokines, Periodontitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Queensland, Metro North Hospital and Health Service, School of Dentistry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the clinical, microbial and cytokine changes following the use of oral azithromycin as an adjunct to non‐surgical subgingival instrumentation (NSI) in stage III/IV, grade C periodontitis through a triple‐blind, parallel‐armed, randomised controlled trial. Material and Methods A total of 52 patients with stage III/IV grade C periodontitis were randomly allocated to two groups receiving NSI with or without adjunctive azithromycin. The primary outcome was changes in the periodontal inflamed surface area (PISA) values over 12 months, and the secondary outcomes included changes in pocket depth (PD), clinical attachment loss (CAL), percentage of sites with PD of 1–3, 4–5, ≥ 5 and ≥ 6 mm, subgingival periodontal pathogens, cytokine levels and patient‐reported outcomes.

Results

At 3 and 12 months, there were no statistically significant differences in the reduction in PISA or other clinical parameters between the groups. At 3 months, the levels of several periodontal pathogens were significantly reduced in the azithromycin group. No significant differences were observed in the levels of periodontal pathogens at 12 months except for Prevotella intermedia. No significant differences were observed for the studied cytokines at 3 and 12 months.

Conclusion

The results of this study do not support the use of systemic azithromycin in stage III/IV, grade C periodontitis. Trial Registration: The trial was registered prospectively in the Australia New Zealand Clinical Trial Registry, ACTRN12619000560190. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374699

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinAnti-Bacterial AgentsCytokinesPeriodontitisHumansFemaleMaleMiddle AgedAdultTreatment OutcomeCombined Modality TherapyPeriodontal IndexDental Scaling

Stichwörter der Autor:innen

azithromycincytokinesmicrobiologypatient‐reported outcome measuresperiodontitisstaging and grading

Substanzen

AzithromycinAnti-Bacterial AgentsCytokines

Autor:innen und Institutionen

  • Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia.
  • Preventive Dental Sciences, College of Dentistry, Gulf Medical University, Ajman, UAE.
  • Oral Health Centre, Metro North Oral Health Services, Herston, Queensland, Australia.

ORCID-Profile: Srinivas Sulugodu Ramachandra, Valerie Woodford, Pingping Han, Ryan S B Lee, Sašo Ivanovski

Förderung

  • University of Queensland
  • Metro North Hospital and Health Service
  • School of Dentistry
  • Queensland Government

Zitieren

APA

Sulugodu Ramachandra, S., Woodford, V., Han, P., Lee, R. S. B., & Ivanovski, S. (2025). Systemic Azithromycin as an Adjunct to Non‐Surgical Subgingival Instrumentation in the Treatment of Stage III / IV , Grade C Periodontitis: 12‐Month Clinical, Microbiological and Cytokine Results of a Randomised Controlled Trial. Journal of Clinical Periodontology, 52(5), 666-680. https://doi.org/10.1111/jcpe.14150

Vancouver

Sulugodu Ramachandra S, Woodford V, Han P, Lee RSB, Ivanovski S. Systemic Azithromycin as an Adjunct to Non‐Surgical Subgingival Instrumentation in the Treatment of Stage III / IV , Grade C Periodontitis: 12‐Month Clinical, Microbiological and Cytokine Results of a Randomised Controlled Trial. Journal of Clinical Periodontology. 2025;52(5):666-680. doi:10.1111/jcpe.14150

BibTeX
@article{SulugoduRamachandra2025,
  author = {Sulugodu Ramachandra, Srinivas and Woodford, Valerie and Han, Pingping and Lee, Ryan S B and Ivanovski, Sašo},
  title = {Systemic Azithromycin as an Adjunct to Non‐Surgical Subgingival Instrumentation in the Treatment of Stage III / IV , Grade C Periodontitis: 12‐Month Clinical, Microbiological and Cytokine Results of a Randomised Controlled Trial},
  journal = {Journal of Clinical Periodontology},
  year = {2025},
  volume = {52},
  number = {5},
  pages = {666--680},
  doi = {10.1111/jcpe.14150}
}
Kostenlos starten →